RecruitingNCT01186133
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Sponsor
Seung-Jung Park
Enrollment
50,000 participants
Start Date
Jan 1, 2009
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
Eligibility
Min Age: 19 Years
Inclusion Criteria2
- coronary disease amenable to percutaneous coronary intervention (PCI)
- no clinical and lesion limitations
Exclusion Criteria3
- patients with a mixture of several DES
- terminal illness with life expectancy less than 1 year
- patients with cardiogenic shock
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01186133
Related Trials
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120146 locations
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NCT0719069012 locations
Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
NCT062590194 locations
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT0677963017 locations
Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure
NCT057703491 location